Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (441-450 of 1,137) with videos related to

Pageof 114
Sort By:
Journal of the American Society of Nephrology : JASN|May 17, 2017
Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney FunctionJohn W Stanifer, David M Charytan, Jennifer White, et al.
European Heart Journal|February 18, 2015
Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trialChristopher P Cannon, Bertrand Cariou, Dirk Blom, et al.
Placenta|December 3, 2014
Stability of absolute copy number of housekeeping genes in preeclamptic and normal placentas, as measured by digital PCRT J Kaitu'u-Lino, R Hastie, P Cannon, et al.
JAMA|December 27, 2002
Benefit of an early invasive management strategy in women with acute coronary syndromesRuchira Glaser, Howard C Herrmann, Sabina A Murphy, et al.
Circulation|March 16, 2006
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trialMichelle O'Donoghue, David A Morrow, Marc S Sabatine, et al.
American Heart Journal|June 25, 2004
Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18John V Wylie, Sabina A Murphy, David A Morrow, et al.
The American Journal of Cardiology|June 17, 2000
Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials)J Llevadot, R P Giugliano, C H McCabe, et al.
The American Journal of Cardiology|February 12, 2002
Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromesTorbjørn Omland, James A de Lemos, David A Morrow, et al.
Journal of Pediatric Hematology/Oncology|March 16, 2007
Primary tuberculosis of bone mimicking a lytic bone tumorScott D Lemme, Austin Kevin Raymond, Christopher P Cannon, et al.
Critical Pathways in Cardiology|March 15, 2008
Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudyNasser Lakkis, Valeri Tsyboulev, C Michael Gibson, et al.
Pageof 114

Showing results (441-450 of 1,137) with videos related to

Sort By:
Pageof 114
Journal of the American Society of Nephrology : JASN|May 17, 2017
Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney FunctionJohn W Stanifer, David M Charytan, Jennifer White, et al.
European Heart Journal|February 18, 2015
Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trialChristopher P Cannon, Bertrand Cariou, Dirk Blom, et al.
Placenta|December 3, 2014
Stability of absolute copy number of housekeeping genes in preeclamptic and normal placentas, as measured by digital PCRT J Kaitu'u-Lino, R Hastie, P Cannon, et al.
JAMA|December 27, 2002
Benefit of an early invasive management strategy in women with acute coronary syndromesRuchira Glaser, Howard C Herrmann, Sabina A Murphy, et al.
Circulation|March 16, 2006
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trialMichelle O'Donoghue, David A Morrow, Marc S Sabatine, et al.
American Heart Journal|June 25, 2004
Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18John V Wylie, Sabina A Murphy, David A Morrow, et al.
The American Journal of Cardiology|June 17, 2000
Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials)J Llevadot, R P Giugliano, C H McCabe, et al.
The American Journal of Cardiology|February 12, 2002
Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromesTorbjørn Omland, James A de Lemos, David A Morrow, et al.
Journal of Pediatric Hematology/Oncology|March 16, 2007
Primary tuberculosis of bone mimicking a lytic bone tumorScott D Lemme, Austin Kevin Raymond, Christopher P Cannon, et al.
Critical Pathways in Cardiology|March 15, 2008
Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudyNasser Lakkis, Valeri Tsyboulev, C Michael Gibson, et al.
Pageof 114